MyBody-X angle on Kefir Genetik

MyBody-X offers DNA tests that may include genes such as LCT (lactase persistence) or TAS2R38 (bitter taste), which could indirectly relate to kefir consumption. Lactose intolerance affects tolerance of dairy-based kefir, and bitter sensitivity may influence acceptance of its tangy flavor. However, no robust studies support a direct 'kefir genetics' link. MyBody-X might include these markers in broader nutrigenetics or microbiome panels, but the clinical utility is limited. Evidence for personalized kefir recommendations based on these genes is weak. Consumers should be cautious of marketing claims that a DNA test can predict the ideal kefir type or dosage. Individual tolerance and clinical tests (e.g., lactose tolerance test) are more informative. MyBody-X should transparently communicate these limitations.